Details of the Drug
General Information of Drug (ID: DM5VLIE)
| Drug Name |
1,2,3,4-Tetrahydro-isoquinolin-7-ol
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
1,2,3,4-tetrahydroisoquinolin-7-ol; 30798-64-2; 1,2,3,4-Tetrahydro-isoquinolin-7-ol; 1,2,3,4-Tetrahydro-7-isoquinolinol; 7-Hydroxy-1,2,3,4-tetrahydroisoquinoline; CHEMBL27730; RADQTHXRZJGDQI-UHFFFAOYSA-N; 7-Isoquinolinol, 1,2,3,4-tetrahydro-; 1,2,3,4-Tetrahydro-iosquinoline-7-ol; AC1L9HE2; 7-Hydroxytetrahydroisochinolin; SCHEMBL470826; AC1Q798F; DTXSID40329303; MolPort-005-312-666; ZINC3847389; BDBM50024826; ANW-75301; AKOS006222928; MB05747; RP21285; AC-9597; MCULE-2692939705; KB-74165; KB-64192; BS-13490; AJ-45863; TC-062003
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 149.19 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


